{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:21:46Z","timestamp":1772166106289,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetes mellitus (DM) type 2 is an independent risk factor for atrial fibrillation (AF). Surgical ablation or \"maze procedure\" is an option for patients with AF undergoing concomitant or isolated cardiac surgery. The aim of this study was to evaluate the impact of DM type 2 on early and long-term outcomes of patients following surgical AF ablation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed an observational cohort study in Israel\u2019s largest tertiary care center. All data of patients who underwent surgical AF ablation, between 2006 and 2021 were extracted from our departmental database. Patients were divided into Group I (non-diabetic patients) and Group II (DM type 2 patients). We compared the two groups with respect to freedom from recurrent atrial arrhythmia, and mortality rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study population included 606 patients. Group I (non-DM patients), consisting of 484 patients, and Group II (DM type 2 patients), comprised 122 patients. Patients with DM were older, had more hypertension and incidence of cerebrovascular accident (CVA)\/transient ischemic attack (TIA), higher EuroSCORE (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009.05 for all), and a longer bypass time\u2014130\u2009\u00b1\u200940 vs. 122\u2009\u00b1\u200936\u00a0min (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.028). The mean follow-up duration was 39.0\u2009\u00b1\u200922.7\u00a0months. Freedom from atrial fibrillation was similar between the non-DM and DM type 2 groups after a 1-year follow-up, 414 (88.2%) vs. 101 (87.1%) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.511), after a 3-year follow-up, 360 (86.3%) vs. 84 (79.9%) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.290) and after a 5-year follow-up, 226 (74.1%) vs. 55 (71.5%) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.622) respectively. Furthermore, 1- and 3-year mortality was similar between non-DM and DM type 2 groups, 2.5% vs. 4.9%, (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.226) and 5.6% vs. 10.5% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.076) respectively. 5-year mortality was higher in Group II (DM type 2 patients) compared with Group I (non-DM patients), 11.1% vs. 23.4% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.009).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Surgical ablation had a high success rate, with freedom from recurrent atrial arrhythmia at 1- 3- and 5- years follow-up in both the DM type 2 and non-DM groups. Furthermore,1- and 3-year mortality after surgical ablation was also similar in both groups. However, 5-year mortality was higher in the DM type 2 group.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-023-01810-x","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T12:02:56Z","timestamp":1680264176000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Surgical ablation for atrial fibrillation: impact of Diabetes Mellitus type 2"],"prefix":"10.1186","volume":"22","author":[{"given":"Alexander","family":"Kogan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avishay","family":"Grupper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avi","family":"Sabbag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eilon","family":"Ram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamer","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyal","family":"Nof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique Z.","family":"Fisman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shany","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy","family":"Beinart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Frogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehud","family":"Raanani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonid","family":"Sternik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,31]]},"reference":[{"issue":"8","key":"1810_CR1","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jacc.2019.07.020","volume":"74","author":"A Wang","year":"2019","unstructured":"Wang A, Green JB, Halperin JL, Piccini JP Sr. Atrial Fibrillation and diabetes mellitus: JACC Review topic of the week. J Am Coll Cardiol. 2019;74(8):1107\u201315. https:\/\/doi.org\/10.1016\/j.jacc.2019.07.020.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1810_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5837\/bjc.2022.008","volume":"29","author":"A Hall","year":"2022","unstructured":"Hall A, Mitchell ARJ, Ashmore L, Holland C. Atrial fibrillation prevalence and predictors in patients with diabetes: a cross-sectional screening study. Br J Cardiol. 2022;29(1):8. https:\/\/doi.org\/10.5837\/bjc.2022.008.","journal-title":"Br J Cardiol"},{"issue":"1","key":"1810_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12933-021-01318-2","volume":"20","author":"J Gumprecht","year":"2021","unstructured":"Gumprecht J, Lip GYH, Sokal A, \u015aredniawa B, Mitr\u0119ga K, Stokwiszewski J, et al. Relationship between diabetes mellitus and atrial fibrillation prevalence in the Polish population: a report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study. Cardiovasc Diabetol. 2021;20(1):128. https:\/\/doi.org\/10.1186\/s12933-021-01318-2.","journal-title":"Cardiovasc Diabetol"},{"key":"1810_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12933-022-01549-x","volume":"21","author":"Y-H Chan","year":"2022","unstructured":"Chan Y-H, Chao T-Z, Chen S-W, Lee H-F, Li P-R, Chen W-M, et al. The risk of incident atrial fibrillation in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors: a nationwide cohort study. Cardiovasc Diabetol. 2022;21:118.","journal-title":"Cardiovasc Diabetol"},{"key":"1810_CR5","doi-asserted-by":"publisher","first-page":"921159","DOI":"10.3389\/fendo.2022.921159","volume":"13","author":"J Xu","year":"2022","unstructured":"Xu J, Sun Y, Gong D, Fan Y. Impact of preexisting diabetes mellitus on cardiovascular and all-cause mortality in patients with atrial fibrillation: a meta-analysis. Front Endocrinol. 2022;13:921159. https:\/\/doi.org\/10.3389\/fendo.2022.921159.","journal-title":"Front Endocrinol"},{"issue":"5","key":"1810_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373\u2013498. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612.","journal-title":"Eur Heart J"},{"issue":"2","key":"1810_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1053\/j.semtcvs.2019.02.026","volume":"31","author":"M Alreshidan","year":"2019","unstructured":"Alreshidan M, Roberts HG, Rankin JS, Wei LM, Badhwar V. Current approach to surgical ablation for Atrial Fibrillation. Semin Thorac Cardiovasc Surg. 2019;31(2):141\u20135. https:\/\/doi.org\/10.1053\/j.semtcvs.2019.02.026.","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"3","key":"1810_CR8","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/jamacardio.2016.5404","volume":"2","author":"MD Huffman","year":"2017","unstructured":"Huffman MD, Malaisrie SC, Karmali KN. Concomitant Atrial Fibrillation surgery for people undergoing cardiac surgery. JAMA Cardiol. 2017;2(3):334\u20135. https:\/\/doi.org\/10.1001\/jamacardio.2016.5404.","journal-title":"JAMA Cardiol"},{"issue":"6","key":"1810_CR9","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1016\/j.athoracsur.2015.06.028","volume":"100","author":"Z Li","year":"2015","unstructured":"Li Z, Amsterdam EA, Young JN, Hoegh H, Armstrong EJ. Contemporary outcomes of coronary artery bypass grafting among patients with insulin-treated and non-insulin-treated diabetes. Ann Thorac Surg. 2015;100(6):2262\u20139. https:\/\/doi.org\/10.1016\/j.athoracsur.2015.06.028.","journal-title":"Ann Thorac Surg"},{"issue":"Suppl 1","key":"1810_CR10","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc16-S005","volume":"39","author":"American Diabetes Association","year":"2016","unstructured":"American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2016;39(Suppl 1):S13-22. https:\/\/doi.org\/10.2337\/dc16-S005.","journal-title":"Diabetes Care"},{"issue":"1","key":"1810_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/s1010-7940(99)00134-7","volume":"16","author":"SA Nashef","year":"1999","unstructured":"Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16(1):9\u201313. https:\/\/doi.org\/10.1016\/s1010-7940(99)00134-7.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"1810_CR12","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.athoracsur.2008.11.011","volume":"87","author":"HL Lazar","year":"2009","unstructured":"Lazar HL, McDonnell M, Chipkin SR, Furnary AP, Engelman RM, Sadhu AR, et al. Society of Thoracic Surgeons Blood Glucose Guideline Task Force The Society of Thoracic Surgeons practice guideline series: blood glucose management during adult cardiac surgery. Ann Thorac Surg. 2009;87(2):663\u20139. https:\/\/doi.org\/10.1016\/j.athoracsur.2008.11.011.","journal-title":"Ann Thorac Surg"},{"key":"1810_CR13","unstructured":"R: The R Project for Statistical Computing (r-project.org). https:\/\/www.r-project.org\/ Accessed 08.12.2022"},{"issue":"9","key":"1810_CR14","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1080\/14779072.2022.2115357","volume":"20","author":"M Yildiz","year":"2022","unstructured":"Yildiz M, Lavie CJ, Morin DP, Oktay AA. The complex interplay between diabetes mellitus and atrial fibrillation. Expert Rev Cardiovasc Ther. 2022;20(9):707\u201317. https:\/\/doi.org\/10.1080\/14779072.2022.2115357.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"1810_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12933-022-01473-0","volume":"21","author":"AS Papazoglou","year":"2022","unstructured":"Papazoglou AS, Kartas A, Moysidis DV, Tsagkaris C, Papadakos SP, Bekiaridou A, et al. Glycemic control and atrial fibrillation: an intricate relationship, yet under investigation. Cardiovasc Diabetol. 2022;21:39.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"1810_CR16","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/ejcts\/ezx179","volume":"52","author":"W Gu","year":"2017","unstructured":"Gu W, Guo H, Lu C, Huang H, Liu J, Liu J, et al. Surgical ablation for persistent atrial fibrillation in concomitant cardiac surgery: mid-long-term result. Eur J Cardiothorac Surg. 2017;52(5):888\u201394. https:\/\/doi.org\/10.1093\/ejcts\/ezx179.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"1810_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1053\/j.jvca.2019.09.021","volume":"34","author":"K Raissouni","year":"2020","unstructured":"Raissouni K, Petrosyan A, Malapert G, Jazayeri S, Morgant MC, Bouchot O. Concomitant cardiac surgery and radiofrequency ablation of Atrial Fibrillation: a retrospective single center study. J Cardiothorac Vasc Anesth. 2020;34(2):401\u20138. https:\/\/doi.org\/10.1053\/j.jvca.2019.09.021.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"5","key":"1810_CR18","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1016\/j.jtcvs.2019.10.186","volume":"161","author":"J Petersen","year":"2021","unstructured":"Petersen J, Vettorazzi E, Hakmi S, Alassar Y, Meyer C, Willems S, et al. Should concomitant surgical ablation for atrial fibrillation be performed in elderly patients? J Thorac Cardiovasc Surg. 2021;161(5):1816-1823.e1. https:\/\/doi.org\/10.1016\/j.jtcvs.2019.10.186.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"1810_CR19","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1053\/j.semtcvs.2017.08.015","volume":"29","author":"S Pecha","year":"2017","unstructured":"Pecha S, Ghandili S, Hakmi S, Willems S, Reichenspurner H, Wagner FM. Predictors of long-term success after concomitant surgical ablation for Atrial Fibrillation. Semin Thorac Cardiovasc Surg. 2017;29(3):294\u20138. https:\/\/doi.org\/10.1053\/j.semtcvs.2017.08.015.","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"4","key":"1810_CR20","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.jtcvs.2018.09.131","volume":"157","author":"N Ad","year":"2019","unstructured":"Ad N, Holmes SD, Rongione AJ, Badhwar V, Wei L, Fornaresio LM, et al. The long-term safety and efficacy of concomitant Cox maze procedures for atrial fibrillation in patients without mitral valve disease. J Thorac Cardiovasc Surg. 2019;157(4):1505\u201314. https:\/\/doi.org\/10.1016\/j.jtcvs.2018.09.131.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"17","key":"1810_CR21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.xjtc.2022.11.009","volume":"5","author":"MMO McGilvray","year":"2022","unstructured":"McGilvray MMO, Barron L, Yates TE, Zemlin CW, Damiano RJ Jr. The Cox-Maze procedure: What lesions and why. JTCVS Tech. 2022;5(17):84\u201393. https:\/\/doi.org\/10.1016\/j.xjtc.2022.11.009.","journal-title":"JTCVS Tech"},{"issue":"3","key":"1810_CR22","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.hroo.2020.04.006","volume":"1","author":"A Wang","year":"2020","unstructured":"Wang A, Truong T, Black-Maier E, Green C, Campbell KB, Barnett AS, et al. Catheter ablation of atrial fibrillation in patients with diabetes mellitus. Heart Rhythm O2. 2020;1(3):180\u20138. https:\/\/doi.org\/10.1016\/j.hroo.2020.04.006.","journal-title":"Heart Rhythm O2"},{"issue":"6","key":"1810_CR23","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.amjcard.2019.12.037","volume":"125","author":"A Creta","year":"2020","unstructured":"Creta A, Provid\u00eancia R, Adrag\u00e3o P, de Asmundis C, Chun J, Chierchia G, et al. Impact of Type-2 diabetes mellitus on the outcomes of catheter ablation of Atrial Fibrillation (European Observational Multicentre Study). Am J Cardiol. 2020;125(6):901\u20136. https:\/\/doi.org\/10.1016\/j.amjcard.2019.12.037.","journal-title":"Am J Cardiol"},{"issue":"1","key":"1810_CR24","doi-asserted-by":"publisher","first-page":"6890","DOI":"10.1038\/s41598-019-43283-7","volume":"9","author":"YG Kim","year":"2019","unstructured":"Kim YG, Choi JI, Boo KY, Kim DY, Oh SK, Park HS, et al. Clinical and echocardiographic risk factors predict late recurrence after radiofrequency catheter ablation of Atrial Fibrillation. Sci Rep. 2019;9(1):6890. https:\/\/doi.org\/10.1038\/s41598-019-43283-7.","journal-title":"Sci Rep"},{"issue":"1","key":"1810_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ahj.2014.10.013","volume":"169","author":"M Koshizaka","year":"2015","unstructured":"Koshizaka M, Lopes RD, Reyes EM, Gibson CM, Schulte PJ, Hafley GE, et al. Long-term clinical and angiographic outcomes in patients with diabetes undergoing coronary artery bypass graft surgery: results from the project of ex-vivo vein graft engineering via transfection IV trial. Am Heart J. 2015;169(1):175\u201384. https:\/\/doi.org\/10.1016\/j.ahj.2014.10.013.","journal-title":"Am Heart J"},{"issue":"1","key":"1810_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12933-018-0796-7","volume":"17","author":"A Kogan","year":"2018","unstructured":"Kogan A, Ram E, Levin S, Fisman EZ, Tenenbaum A, Raanani E, et al. Impact of type 2 diabetes mellitus on short- and long-term mortality after coronary artery bypass surgery. Cardiovasc Diabetol. 2018;17(1):151. https:\/\/doi.org\/10.1186\/s12933-018-0796-7.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1810_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12933-019-0836-y","volume":"18","author":"E Ram","year":"2019","unstructured":"Ram E, Kogan A, Levin S, Fisman EZ, Tenenbaum A, Raanani E, et al. Type 2 diabetes mellitus increases long-term mortality risk after isolated surgical aortic valve replacement. Cardiovasc Diabetol. 2019;18(1):31. https:\/\/doi.org\/10.1186\/s12933-019-0836-y.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"1810_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.48729\/pjctvs.266","volume":"29","author":"P Veiga Oliveira","year":"2022","unstructured":"Veiga Oliveira P, Madeira M, Ranchord\u00e1s S, Nolasco T, Marques M, Sousa-Uva M, Abecasis M, Neves JP. Triple valve surgery: long-term follow-up from a single centre. Port J Card Thorac Vasc Surg. 2022;29(2):23\u20139. https:\/\/doi.org\/10.48729\/pjctvs.266.","journal-title":"Port J Card Thorac Vasc Surg"}],"updated-by":[{"DOI":"10.1186\/s12933-023-01851-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000}}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01810-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-01810-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01810-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T05:06:28Z","timestamp":1684472788000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-01810-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1810"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-01810-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2626452\/v1","asserted-by":"object"}]},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,31]]},"assertion":[{"value":"25 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12933-023-01851-2","URL":"https:\/\/doi.org\/10.1186\/s12933-023-01851-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sheba Medical Center (Ramat Gan, Israel) Institutional Ethical Committee (Protocol No 4257).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}